l-carnitine chemotherapy neuropathy Chemotherapy-induced peripheral neuropathy: part 1—current state of knowledge and perspectives for pharmacotherapy | Pharmacological Reports Management of Chemotherapy-Induced Peripheral Neuropathy
Description
We utilized RNA sequencing, bioinformatic approaches, and both in vivo and in vitro experiments to confirm that TMAO promotes cholelithiasis by dysregulating hepatic cholesterol metabolism through its effects on the key regulatory genes apolipoprotein A4 ( APOA4) and proprotein convertase subtilisin/kexin type 9 ( PCSK9 )
ATB 0,+ mediates the transport of all proteogenic amino acids except for aspartate and glutamate
Protective role of L-carnitine on liver and heart lipid peroxidation in atherosclerotic rats
Installation Service is Available
10.1002/jdn.10025 41 DellapiazzaF.MichelonC.RattazC.PicotM.-C.BaghdadliA
